Mr. Mohan Rk Nimmagadda

Mohan RK Nimmagadda, CEO

This product is used to analyse any kind of experimental data in biological research," Helix Genomics director Mohan RK Nimmagadda said.

Elaborating on the HGPL plans, Mr. Mohan RK Nimmagadda, CEO and Director stated that HGPL is ambitious and will be improving its target base to eventually emerge as the global Bio-Computational CRO major and provide comprehensive and customized solutions to the industry.

The licence has been extended to cover all the research labs at the School of Life Sciences, University of Hyderabad, facilitating in building long-term research collaboration with HGPL delivering better and faster computational solutions, HGPL chief executive officer Mohan RK Nimmagadda said.
...
With BOS, one can expect, on an average, about 60-75% savings on researcher time and similar equivalents on the research costs, Mr Nimmagadda added.

Elaborating on the HGPL plans, Mr. Mohan RK Nimmagadda, CEO and Director stated that HGPL is ambitious and will be improving its target base to eventually emerge as the global Bio-Computational CRO major and provide comprehensive and customized solutions to the industry.

HGPL Announces Global CR Model/ Posted on 08th Jul 2004.
...
Announcing this, Mr. Mohan RK Nimmagadda, CEO, HGPL further stated that presently, our attorneys include Boehmert & Boehmert at Munich, Germany which by and large represents our interests at EU and USA through their associates Saliwanchik, Lloyd & Saliwanchik.
...
According to Mr. Mohan RK Nimmagadda, Director& CEO for HGPL, stated that we are the first University based Start-Up in Computational Biology to get the Seed Capital and Technology Incubation.

Hence there is a need for a systematic study of structure-function relationship for efficient design/engineering of bio-macromolecules, Mohan RK Nimmagadda, chief executive officer of Helix Genomics told eFE.

"The MACS solution is an attempt to extract function-related information from the structure of the macromolecules in general and proteins in particular.Using reverse engineering principles, functional data is interpolated to derive structural information, which is then used to design molecules of commercial interests," he elaborated.
...
Our patented technologies can be used in identifying such hot spots in the proteins, which can be cloned and expressed using molecular biology techniques," Mr Nimmagadda pointed out.Further he said that Helix's interests in the current project are limited to studies on industrially important enzymes such as proteinases, amylases and lipases.

The licence has been extended to cover all the research labs at the School of Life Sciences, University of Hyderabad, facilitating in building long-term research collaboration with HGPL delivering better and faster computational solutions, HGPL chief executive officer Mohan RK Nimmagadda said.

Meanwhile, BOS has been extensively validated for more than 1,500 man-hours on its modules and applications using in-house and contract research projects from Europe and India.Projects include solving biological data redundancy problems in public databases, creation of unique databases of repeat sequences, restriction enzymes and oncologically significant novel genes.With BOS, one can expect, on an average, about 60-75% savings on researcher time and similar equivalents on the research costs, Mr Nimmagadda added.

The licence has been extended to cover all the research labs at the School of Life Sciences, University of Hyderabad, facilitating in building long-term research collaboration with HGPL delivering better and faster computational solutions, HGPL chief executive officer Mohan RK Nimmagadda said.

Meanwhile, BOS has been extensively validated for more than 1,500 man-hours on its modules and applications using in-house and contract research projects from Europe and India.Projects include solving biological data redundancy problems in public databases, creation of unique databases of repeat sequences, restriction enzymes and oncologically significant novel genes.With BOS, one can expect, on an average, about 60-75% savings on researcher time and similar equivalents on the research costs, Mr Nimmagadda added.

Enter a keyword e.g. Satyam